Product Code: MRR-50124643641B
[184 Pages Report] The Rapid Microbiology Testing Market size was estimated at USD 4.75 billion in 2023 and expected to reach USD 5.15 billion in 2024, at a CAGR 8.50% to reach USD 8.41 billion by 2030.
Global Rapid Microbiology Testing Market
KEY MARKET STATISTICS |
Base Year [2023] |
USD 4.75 billion |
Estimated Year [2024] |
USD 5.15 billion |
Forecast Year [2030] |
USD 8.41 billion |
CAGR (%) |
8.5% |
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Rapid Microbiology Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Rapid Microbiology Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Rapid Microbiology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Inc., Becton, Dickinson and Company, bioMerieux SA, Bruker Corporation, Charles River Laboratories International, Inc., Colifast AS, Don Whitley Scientific Limited, Gradientech AB, Merck KGaA, NEOGEN Corporation, Quidel Corporation, R-Biopharm AG, Rapid Micro Biosystems, Inc., rqmicro AG, Sartorius AG, Serosep Ltd., Thermo Fisher Scientific, Inc., and Vivione Biosciences, LLC.
Market Segmentation & Coverage
This research report categorizes the Rapid Microbiology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Consumables
- Instruments
- Active Air Samplers
- Automated Microbial Identification & Antimicrobial Susceptibility Testing System
- Bioluminescence & Fluorescence-Based Detection System
- Cytometers
- Mass Spectrometers
- PCR Systems
- Reagents & Kits
- Sterility Reagents & Kits
- Method
- Cellular Component-Based Rapid Microbiology Testing
- Growth-Based Rapid Microbiology Testing
- Nucleic Acid-Based Rapid Microbiology Testing
- Viability-Based Rapid Microbiology Testing
- Application
- Clinical Disease Diagnostics
- Cosmetics & Personal Care Products Testing
- Environmental Testing
- Food & Beverage testing
- Pharmaceutical & Biological Drug Testing
- Research Applications
- End-User
- Academic Institutes
- Contract Research Organizations
- Cosmetics & Personal Care Testing Industry
- Diagnostic Laboratories & Hospitals
- Environmental Study Agencies
- Food & Beverage Companies
- NGOs
- Pharmaceutical & Biotechnology Companies
- Research Laboratories
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Rapid Microbiology Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Rapid Microbiology Testing Market?
3. What are the technology trends and regulatory frameworks in the Rapid Microbiology Testing Market?
4. What is the market share of the leading vendors in the Rapid Microbiology Testing Market?
5. Which modes and strategic moves are suitable for entering the Rapid Microbiology Testing Market?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
- 4.1. Introduction
- 4.2. Rapid Microbiology Testing Market, by Region
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing incidence of infectious diseases and cancer
- 5.1.1.2. Technological advancements in rapid microbiology testing
- 5.1.1.3. Increased funding for R&D
- 5.1.2. Restraints
- 5.1.2.1. The stringent regulations related to rapid microbiology testing kits
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in the rapid microbiology testing kits
- 5.1.3.2. Increase in the number of research activities for Microbiology testing
- 5.1.4. Challenges
- 5.1.4.1. High capital investments and low cost-benefit ratio
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
6. Rapid Microbiology Testing Market, by Product
- 6.1. Introduction
- 6.2. Consumables
- 6.3. Instruments
- 6.4.1. Active Air Samplers
- 6.4.2. Automated Microbial Identification & Antimicrobial Susceptibility Testing System
- 6.4.3. Bioluminescence & Fluorescence-Based Detection System
- 6.4.4. Cytometers
- 6.4.5. Mass Spectrometers
- 6.4.6. PCR Systems
- 6.4. Reagents & Kits
- 6.5.1. Sterility Reagents & Kits
7. Rapid Microbiology Testing Market, by Method
- 7.1. Introduction
- 7.2. Cellular Component-Based Rapid Microbiology Testing
- 7.3. Growth-Based Rapid Microbiology Testing
- 7.4. Nucleic Acid-Based Rapid Microbiology Testing
- 7.5. Viability-Based Rapid Microbiology Testing
8. Rapid Microbiology Testing Market, by Application
- 8.1. Introduction
- 8.2. Clinical Disease Diagnostics
- 8.3. Cosmetics & Personal Care Products Testing
- 8.4. Environmental Testing
- 8.5. Food & Beverage testing
- 8.6. Pharmaceutical & Biological Drug Testing
- 8.7. Research Applications
9. Rapid Microbiology Testing Market, by End-User
- 9.1. Introduction
- 9.2. Academic Institutes
- 9.3. Contract Research Organizations
- 9.4. Cosmetics & Personal Care Testing Industry
- 9.5. Diagnostic Laboratories & Hospitals
- 9.6. Environmental Study Agencies
- 9.7. Food & Beverage Companies
- 9.8. NGOs
- 9.9. Pharmaceutical & Biotechnology Companies
- 9.10. Research Laboratories
10. Americas Rapid Microbiology Testing Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
11. Asia-Pacific Rapid Microbiology Testing Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
12. Europe, Middle East & Africa Rapid Microbiology Testing Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories, Inc.
- 14.1.2. Becton, Dickinson and Company
- 14.1.3. bioMerieux SA
- 14.1.4. Bruker Corporation
- 14.1.5. Charles River Laboratories International, Inc.
- 14.1.6. Colifast AS
- 14.1.7. Don Whitley Scientific Limited
- 14.1.8. Gradientech AB
- 14.1.9. Merck KGaA
- 14.1.10. NEOGEN Corporation
- 14.1.11. Quidel Corporation
- 14.1.12. R-Biopharm AG
- 14.1.13. Rapid Micro Biosystems, Inc.
- 14.1.14. rqmicro AG
- 14.1.15. Sartorius AG
- 14.1.16. Serosep Ltd.
- 14.1.17. Thermo Fisher Scientific, Inc.
- 14.1.18. Vivione Biosciences, LLC
- 14.2. Key Product Portfolio
15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing